Cargando…

DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver

Levels of omega-6 (n-6) and omega-3 (n-3), long chain polyunsaturated fatty acids (LcPUFAs) such as arachidonic acid (AA; 20∶4, n-6), eicosapentaenoic acid (EPA; 20∶5, n-3) and docosahexaenoic acid (DHA; 22∶6, n-3) impact a wide range of biological activities, including immune signaling, inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Timothy D., Mathias, Rasika A., Seeds, Michael C., Herrington, David M., Hixson, James E., Shimmin, Lawrence C., Hawkins, Greg A., Sellers, Matthew, Ainsworth, Hannah C., Sergeant, Susan, Miller, Leslie R., Chilton, Floyd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026313/
https://www.ncbi.nlm.nih.gov/pubmed/24842322
http://dx.doi.org/10.1371/journal.pone.0097510
_version_ 1782316824751243264
author Howard, Timothy D.
Mathias, Rasika A.
Seeds, Michael C.
Herrington, David M.
Hixson, James E.
Shimmin, Lawrence C.
Hawkins, Greg A.
Sellers, Matthew
Ainsworth, Hannah C.
Sergeant, Susan
Miller, Leslie R.
Chilton, Floyd H.
author_facet Howard, Timothy D.
Mathias, Rasika A.
Seeds, Michael C.
Herrington, David M.
Hixson, James E.
Shimmin, Lawrence C.
Hawkins, Greg A.
Sellers, Matthew
Ainsworth, Hannah C.
Sergeant, Susan
Miller, Leslie R.
Chilton, Floyd H.
author_sort Howard, Timothy D.
collection PubMed
description Levels of omega-6 (n-6) and omega-3 (n-3), long chain polyunsaturated fatty acids (LcPUFAs) such as arachidonic acid (AA; 20∶4, n-6), eicosapentaenoic acid (EPA; 20∶5, n-3) and docosahexaenoic acid (DHA; 22∶6, n-3) impact a wide range of biological activities, including immune signaling, inflammation, and brain development and function. Two desaturase steps (Δ6, encoded by FADS2 and Δ5, encoded by FADS1) are rate limiting in the conversion of dietary essential 18 carbon PUFAs (18C-PUFAs) such as LA (18∶2, n-6) to AA and α-linolenic acid (ALA, 18∶3, n-3) to EPA and DHA. GWAS and candidate gene studies have consistently identified genetic variants within FADS1 and FADS2 as determinants of desaturase efficiencies and levels of LcPUFAs in circulating, cellular and breast milk lipids. Importantly, these same variants are documented determinants of important cardiovascular disease risk factors (total, LDL, and HDL cholesterol, triglycerides, CRP and proinflammatory eicosanoids). FADS1 and FADS2 lie head-to-head (5′ to 5′) in a cluster configuration on chromosome 11 (11q12.2). There is considerable linkage disequilibrium (LD) in this region, where multiple SNPs display association with LcPUFA levels. For instance, rs174537, located ∼15 kb downstream of FADS1, is associated with both FADS1 desaturase activity and with circulating AA levels (p-value for AA levels = 5.95×10(−46)) in humans. To determine if DNA methylation variation impacts FADS activities, we performed genome-wide allele-specific methylation (ASM) with rs174537 in 144 human liver samples. This approach identified highly significant ASM with CpG sites between FADS1 and FADS2 in a putative enhancer signature region, leading to the hypothesis that the phenotypic associations of rs174537 are likely due to methylation differences. In support of this hypothesis, methylation levels of the most significant probe were strongly associated with FADS1 and, to a lesser degree, FADS2 activities.
format Online
Article
Text
id pubmed-4026313
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40263132014-05-21 DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver Howard, Timothy D. Mathias, Rasika A. Seeds, Michael C. Herrington, David M. Hixson, James E. Shimmin, Lawrence C. Hawkins, Greg A. Sellers, Matthew Ainsworth, Hannah C. Sergeant, Susan Miller, Leslie R. Chilton, Floyd H. PLoS One Research Article Levels of omega-6 (n-6) and omega-3 (n-3), long chain polyunsaturated fatty acids (LcPUFAs) such as arachidonic acid (AA; 20∶4, n-6), eicosapentaenoic acid (EPA; 20∶5, n-3) and docosahexaenoic acid (DHA; 22∶6, n-3) impact a wide range of biological activities, including immune signaling, inflammation, and brain development and function. Two desaturase steps (Δ6, encoded by FADS2 and Δ5, encoded by FADS1) are rate limiting in the conversion of dietary essential 18 carbon PUFAs (18C-PUFAs) such as LA (18∶2, n-6) to AA and α-linolenic acid (ALA, 18∶3, n-3) to EPA and DHA. GWAS and candidate gene studies have consistently identified genetic variants within FADS1 and FADS2 as determinants of desaturase efficiencies and levels of LcPUFAs in circulating, cellular and breast milk lipids. Importantly, these same variants are documented determinants of important cardiovascular disease risk factors (total, LDL, and HDL cholesterol, triglycerides, CRP and proinflammatory eicosanoids). FADS1 and FADS2 lie head-to-head (5′ to 5′) in a cluster configuration on chromosome 11 (11q12.2). There is considerable linkage disequilibrium (LD) in this region, where multiple SNPs display association with LcPUFA levels. For instance, rs174537, located ∼15 kb downstream of FADS1, is associated with both FADS1 desaturase activity and with circulating AA levels (p-value for AA levels = 5.95×10(−46)) in humans. To determine if DNA methylation variation impacts FADS activities, we performed genome-wide allele-specific methylation (ASM) with rs174537 in 144 human liver samples. This approach identified highly significant ASM with CpG sites between FADS1 and FADS2 in a putative enhancer signature region, leading to the hypothesis that the phenotypic associations of rs174537 are likely due to methylation differences. In support of this hypothesis, methylation levels of the most significant probe were strongly associated with FADS1 and, to a lesser degree, FADS2 activities. Public Library of Science 2014-05-19 /pmc/articles/PMC4026313/ /pubmed/24842322 http://dx.doi.org/10.1371/journal.pone.0097510 Text en © 2014 Howard et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Howard, Timothy D.
Mathias, Rasika A.
Seeds, Michael C.
Herrington, David M.
Hixson, James E.
Shimmin, Lawrence C.
Hawkins, Greg A.
Sellers, Matthew
Ainsworth, Hannah C.
Sergeant, Susan
Miller, Leslie R.
Chilton, Floyd H.
DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title_full DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title_fullStr DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title_full_unstemmed DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title_short DNA Methylation in an Enhancer Region of the FADS Cluster Is Associated with FADS Activity in Human Liver
title_sort dna methylation in an enhancer region of the fads cluster is associated with fads activity in human liver
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026313/
https://www.ncbi.nlm.nih.gov/pubmed/24842322
http://dx.doi.org/10.1371/journal.pone.0097510
work_keys_str_mv AT howardtimothyd dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT mathiasrasikaa dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT seedsmichaelc dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT herringtondavidm dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT hixsonjamese dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT shimminlawrencec dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT hawkinsgrega dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT sellersmatthew dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT ainsworthhannahc dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT sergeantsusan dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT millerleslier dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver
AT chiltonfloydh dnamethylationinanenhancerregionofthefadsclusterisassociatedwithfadsactivityinhumanliver